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Abstract
Objective: To investigate the level and determinants of nonreceipt of contraception 
among women admitted to facilities with abortion- related complications in East and 
Southern Africa.
Methods: Cross- sectional data from Kenya, Malawi, Mozambique, and Uganda col-
lected as part of the World Health Organization (WHO) Multi- Country Survey on 
Abortion- related morbidity. Medical record review and the audio computer- assisted 
self- interviewing system were used to collect information on women's demographic 
and clinical characteristics and their experience of care. The percentage of women 
who did not receive a contraceptive was estimated and the methods of choice for 
different types of contraceptives were identified. Potential determinants of nonre-
ceipt of contraception were grouped into three categories: sociodemographic, clini-
cal, and service- related characteristics. Generalized estimating equations were used 
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1  |  INTRODUCTION
Unintended pregnancy is a global issue that contributes to unsafe 
abortion, and thus, maternal morbidity and mortality. The World 
Health Organization (WHO) reported that 48% of pregnancies 
were unintended between 2015 and 2019,1 with 25 million unsafe 
abortions between 2010 and 2014.2 High- quality postabortion care 
(PAC) is essential to reduce the morbidity and mortality associated 
with unsafe and incomplete abortions. Alongside providing uter-
ine evacuation, treating infection, referring women to other sexual 
health services, and addressing women's psychological and physical 
needs, offering family planning counselling and providing effective 
contraception during PAC is considered best practice by many global 
and national organizations.3,4 For many women, access to effective 
contraceptives is critical for preventing unintended pregnancies, re-
peat abortions, and maternal mortality.5
Despite wide recognition of the importance of providing con-
traceptives as part of PAC, there is limited published literature on 
the levels and determinants of contraceptive uptake among women 
attending facilities for abortion- related complications in East and 
Southern Africa. A systematic review published in 2020 by Izugabara 
et al.6 identified only a small number of studies from sub- Saharan 
Africa that looked at levels of contraceptive uptake among women 
in PAC.7– 9 The estimates varied widely between studies: in Ghana 
in 2012– 2013, for example, 39.9% of women who were receiving 
care for postabortion complications left the facility without a con-
traceptive6; substantially lower estimates of women leaving a facility 
without a contraceptive were found in Tanzania (2004) and Ethiopia 
(2018) (approximately 10%).8,9 In Rwanda in 2012, only 53% of PAC 
clients treated with misoprostol reported receiving a method of con-
traception before discharge.10
It is likely that the vast differences in levels of contraceptive up-
take among women with postabortion complications across these 
studies are driven in part by methodological differences between 
the studies, including the extent to which women with spontaneous 
abortions are included in the sample alongside women with induced 
abortions. However, sociodemographic and health systems factors 
are also likely to explain differences in postabortion uptake of con-
traception across different settings. Previous literature reviews have 
identified factors such as providing contraceptives free of charge, 
providing high- quality counselling, providing couples counselling, 
and expanding the mix of methods offered as linked with higher lev-
els of contraceptive uptake.11,12
In light of the paucity of data on the levels of contraceptive up-
take among women seeking PAC, and the challenge of comparing 
previously published estimates across different settings, the objec-
tive of the present paper is to investigate women's preference for 
contraceptive type, and the level and determinants of nonreceipt of 
contraceptives among women admitted to facilities with abortion- 
related complications in Kenya, Malawi, Mozambique, and Uganda 
using data from the WHO Multi- Country Survey on Abortion- 
related morbidity (MCS- A).
2  | MATERIALS AND METHODS
The cross- sectional MCS- A was conducted between February 
2017 and April 2018. The study methods and key results have been 
to identify the determinants of nonreceipt of a contraceptive following a hierarchical 
approach.
Results: A total of 1190 women with abortion- related complications were included 
in the analysis, of which 33.9% (n = 403) did not receive a contraceptive. We found 
evidence that urban location of facility, no previous pregnancy, and not receiving con-
traceptive counselling were risk factors for nonreceipt of a contraceptive. Women 
from nonurban areas were less likely not to receive a contraceptive than those in 
urban areas (AOR 0.52; 95% CI, 0.30– 0.91). Compared with women who had a previ-
ous pregnancy, women who had no previous pregnancy were 60% more likely to not 
receive a contraceptive (95% CI, 1.14– 2.24). Women who did not receive contracep-
tive counselling were over four times more likely to not receive a contraceptive (AOR 
4.01; 95% CI, 2.88– 5.59).
Conclusion: Many women leave postabortion care having not received contraceptive 
counselling and without a contraceptive method. There is a clear need to ensure all 
women receive high- quality contraceptive information and counselling at the facility 
to increase contraceptive acceptance and informed decision- making.
K E Y WO RD S
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described in detail elsewhere.13,14 In brief, countries and facilities 
were selected for inclusion in the survey through multistage sampling. 
Ultimately, 11 countries were selected from Sub- Saharan Africa, in-
cluding four in Eastern and Southern Africa that were included in the 
present analysis: Kenya, Malawi, Mozambique, and Uganda. Facilities 
were eligible for inclusion if they had more than 1000 deliveries 
per year and capability to provide comprehensive emergency care. 
Further details on the sampling process are provided in Appendix S1.
There were three levels of data collection undertaken at each fa-
cility. Firstly, a facility survey was conducted collecting information 
about each facility's location, capacity, and its availability of abortion/
postabortion services. Secondly, data were extracted from the medical 
records of women who had signs and symptoms of an abortion- related 
complication. Data included a woman's clinical history and the man-
agement of her abortion- related complications. Finally, using conve-
nience sampling, women who were admitted to a hospital for at least 
24 h, and were able and willing to consent, were invited to participate 
in an audio computer- assisted self- interview (ACASI). Only women 
who participated in an ACASI were included in this analysis.
The primary outcome was nonreceipt of contraception, as re-
ported in the ACASI survey. This was defined as any woman who 
reported leaving the facility without being sterilized and not receiv-
ing a contraceptive or a prescription for a contraceptive method. 
Women who reported not being sterilized were also asked about 
their method of choice even if they did not receive it (“Sometimes 
women ask for a form of contraception to prevent future pregnan-
cies. We would like to know the method of your choice even if you 
do not receive it”). They could choose any of the following: oral pills, 
patch, condoms, intrauterine device, implant, injection, and vaginal 
ring. Women were not asked about preference for the patch or vag-
inal ring in Mozambique as these contraceptives were not available 
at the time of the survey.
Potential risk factors for nonreceipt of contraception among 
women with abortion- related complications were broadly catego-
rized into three groups: (1) sociodemographic factors (country, age, 
marital status, occupation status, education level, socioeconomic 
status [SES], and urban versus nonurban location of facility); (2) clin-
ical factors (previous pregnancy, previous abortions, and severity of 
abortion- related complications); and (3) service- related factors (if 
contraceptives were available at the facility, and if the woman re-
ceived contraceptive counselling). A composite measure of SES was 
created using four questions from the ACASI with each question 
contributing equally to the score (questions provided in Table S1). 
Women were subsequently categorized as having low (score 0– 1), 
middle (score 2– 3), and high (score 4) SES. All other sociodemo-
graphic factors and clinical factors were extracted from the medical 
records, with the exception of urban and nonurban, which was in-
ferred from the location of the facility. The nonurban group included 
women who attend facilities in rural or peri- urban areas. Women 
reported in the ACASI if they received contraceptive counselling, 
and information on facility level was extracted from facility survey. 
For potential risk factors with <5% missing data or unknown data, 
this was treated as missing, and individuals with missing data were 
dropped from any analyses including these factors. For potential 
risk factors where more than 5% of respondents had “unknown” re-
sponses, we created an “unknown” group.
Stata version 16.1 (StataCorp LLC) was used for analyses. We con-
ducted descriptive analyses looking at the distribution of the study 
sample by key sociodemographic and clinical characteristics. We cal-
culated the overall prevalence of nonreceipt of contraception in the 
study sample, and examined how this varied by sociodemographic 
characteristics. Among women who reported having a contraceptive 
preference, we also calculated the percentage that reported a prefer-
ence for each contraceptive type, for any short- acting methods, and 
for any long- acting reversible contraception (LARC).
We identified the independent risk factors of nonreceipt of a 
contraceptive using pooled data from the four countries, guided 
by a framework where the risk factors were organized from the 
most distal to most proximate. Generalized estimating equations 
were used for all models to account for within- facility clustering. 
All models were adjusted for country a priori. For all potential 
risk factors, we calculated crude estimates of their association 
with nonreceipt of contraception, adjusting only for country. At 
the first stage of the multivariate modelling process, we inves-
tigated the most distal potential risk factors of nonreceipt of 
contraception— sociodemographic characteristics. We added each 
sociodemographic factor into a multivariable model, starting with 
the factor that was most strongly associated in the crude analysis. 
Sociodemographic factors that remained associated with nonre-
ceipt of contraception at P < 0.10 were considered independent 
risk factors and were retained in the model. At the next stage of 
the modelling process, we added the clinical characteristics to the 
multivariate model, with all the independent sociodemographic 
risk factors included in this model as confounders at this more 
proximate level, and retained any clinical characteristics that were 
associated with nonreceipt of contraceptives at P < 0.10. Finally, 
we looked at the most proximate potential risk factors of nonre-
ceipt of contraceptives— health service- related factors— following 
the same methods as described for the more distal levels.
Once the independent risk factors of nonreceipt of contracep-
tives were identified in the pooled data for East Africa, we assessed 
whether there was any evidence that the association between each 
risk factor and nonreceipt of contraceptives varied by country.
Ethical approval for this analysis was provided by the London 
School of Hygiene and Tropical Medicine's Research Ethics 
Committees (reference: 21909), with approval for the original study 
granted by the local ethics committee within each country and by 
the WHO Ethical Review Committee (protocol: 0002699) and the 
WHO Human Reproduction Programme (HRP) Review Panel on 
Research Projects.
3  |  RESULTS
Figure 1 shows that 1286 women with abortion- related compli-
cations participated in the ACASI survey in the four East Africa 
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countries in the study. Of these women, 50 (3.9%) reported that they 
had had their tubes tied before this facility visit and 46 (3.6%) did 
not provide information on whether they received a contraceptive 
or prescription for a contraceptive, reducing our final sample size to 
1190 women.
The distribution of the study sample by key sociodemographic, 
clinical, and facility- level characteristics is shown in Table 1. Most 
women were married or cohabitating with a partner (n = 815, 
68.5%), lacked gainful occupation (n = 610, 51.3%), and sought care 
in urban locations (n = 802, 67.4%). Educational attainment varied 
by country, with the percentage of women with less than primary 
education varying from 5.5% (n = 6) in Uganda to 44.6% (n = 215) 
in Malawi. Most women had a previous pregnancy (n = 784, 65.9%), 
while 17.3% (n = 206) had a previous abortion. A majority of women 
experienced moderate abortion- related complications during their 
current visit (n = 663, 55.7%).
A total of 48 (4.5%) women reported undergoing a procedure to 
get their tubes tied during the facility visit. Of the remaining 1142 
women, most expressed a preference for one or more types of con-
traceptives (n = 740, 64.8%). The preferences for specific types 
of contraceptives among these 740 women are shown in Figure 2. 
Among women who had a preference for one or more contraceptive, 
361 (48.8%) expressed a preference for both a short- acting method 
and a LARC, 150 (20.3%) stated a preference for a LARC only, and 
229 (30.9%) for a short- acting method only. The pill (n = 348, 47.0%) 
and injections (n = 404, 54.7%) were the most popular method 
of choice among women who expressed a preference, with some 
women expressing a preference for both these methods.
A total of 403 (33.9%) women reported that they left the facil-
ity without a contraceptive or prescription for contraception and 
did not have a procedure to tie their tubes (Table 1). Of these 403 
women, 161 (40.0%) reported they did not receive a contraceptive 
because they wanted to become pregnant again; 104 (25.8%) be-
cause their partner disagrees with using contraception 178 (44.2%) 
because of fear of adverse effects; and 105 (26.1%) because they 
were no longer in a relationship. Of the 403 women, 92 (22.8%) did 
not report any of the reasons, while 142 (35.2%) reported a single 
reason and the remaining women reported more than one reason 
(with 13 women reporting that it was due to all four reasons).
Table 2 shows how nonreceipt of a contraceptive varied by so-
ciodemographic characteristics. In crude analyses, being single or 
separated/divorced/widowed, and being treated in an urban area 
were associated with higher odds of nonreceipt of contraception 
(Table 2). In adjusted analyses, there was evidence of an associ-
ation between location of facility (P = 0.02) with nonreceipt of a 
contraceptive. Women from nonurban areas had half the odds of 
nonreceipt of a contraceptive compared with those treated in urban 
areas (AOR 0.52; 95% CI, 0.30– 0.91). In both crude and adjusted 
analyses, there was strong evidence for an association between 
previous pregnancy and nonreceipt of a contraceptive (P = 0.007). 
After adjusting for facility location and country, women who had not 
had a previous pregnancy were 60% more likely to leave the facility 
without contraception (95% CI, 1.14– 2.24). There was no evidence 
that the other clinical characteristics— repeat abortion and abortion 
complication severity— were associated with nonreceipt of a con-
traceptive after adjusting for country, facility location, and previous 
pregnancy (Table 2).
For the health service factors, crude analysis revealed a strong 
association between contraceptive counselling and nonreceipt of 
contraception (P < 0.001), while there was no evidence of an as-
sociation between the level of the facility and nonreceipt of con-
traception (P = 0.56) (Table 2). The strength of the association for 
contraceptive counselling was maintained after controlling country, 
facility location, and previous pregnancy (P < 0.001); women who 
did not receive counselling were over four times more likely to not 
F I G U R E  1  Inclusion criteria for the study
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TA B L E  1  Baseline distribution of sociodemographic, clinical, and health service- related characteristics of the study sample by country 
(N = 1190). For variables where >5% of data were unknown or missing, we have included these as separate “unknown” categories in the 
distribution
Kenya (n = 507) Mozambique (n = 91) Malawi (n = 482) Uganda (n = 110) Total (n = 1190)
Age group, years
<20 50 (9.9) 15 (16.5) 157 (32.6) 14 (12.7) 236 (19.8)
20– 29 289 (57.0) 41 (45.1) 193 (40.0) 54 (49.1) 577 (48.5)
30+ 163 (32.2) 31 (34.1) 119 (24.7) 39 (35.5) 352 (29.6)
Missing/unknown 5 (1.0) 4 (4.4) 13 (2.7) 3 (2.7) 25 (2.1)
Marital status
Married/cohabiting 340 (67.1) 46 (55.6) 362 (75.1) 67 (60.9) 815 (68.5)
Single 146 (28.8) 43 (47.3) 74 (15.4) 21 (19.1) 284 (23.9)
Separated/divorced/widowed 13 (2.6) 2 (2.2) 8 (1.7) 0 23 (1.9)
Unknown 8 (1.6) 0 38 (7.9) 22 (20.0) 68 (5.7)
Gainful occupation
No 224 (44.2) 61 (67.0) 270 (56.0) 55 (50.0) 610 (51.3)
Yes 256 (50.5) 28 (30.8) 105 (21.8) 30 (27.3) 419 (35.2)
Unknown 27 (5.3) 2 (2.2) 107 (22.2) 107 (22.7) 161 (13.5)
Education level
None/some primary 44 (8.7) 33 (36.2) 215 (44.6) 6 (5.5) 298 (25.0)
Completed primary 185 (36.5) 39 (42.9) 131 (27.2) 23 (20.9) 378 (31.8)
Completed secondary 236 (46.6) 16 (17.6) 45 (9.3) 26 (23.6) 323 (27.1)
Unknown 42 (8.3) 3 (3.3) 91 (18.9) 55 (50.0) 191 (16.1)
Socioeconomic status
Low 115 (22.7) 17 (18.7) 64 (13.3) 27 (24.6) 223 (18.8)
Middle 288 (56.8) 55 (60.4) 292 (60.6) 71 (64.6) 706 (59.3)
High 99 (19.5) 18 (19.8) 125 (25.9) 12 (10.9) 254 (21.3)
Missing 5 (1.1) 1 (1.1) 1(0.2) 0 (0.2) 7 (0.6)
Location at which accessed facility
Urban 434 (85.6) 54 (59.3) 231 (47.9) 83 (75.5) 802 (67.4)
Nonurban 73 (14.4) 37 (40.7) 251 (52.1) 27 (24.6) 388 (32.6)
Any previous pregnancy
No 148 (29.2) 17 (18.7) 170 (35.3) 26 (23.6) 361 (30.3)
Yes 359 (70.8) 71 (78.0) 273 (56.6) 81 (73.6) 784 (65.9)
Missing 0 (0) 3 (3.3) 39 (8.1) 3 (2.7) 45 (3.8)
Any previous abortion
No 392 (77.3) 67 (73.6) 389 (80.7) 67 (60.9) 915 (76.9)
Yes 114 (22.5) 18 (19.8) 53 (11.0) 21 (19.1) 206 (17.3)
Missing/unknown 1 (0.2) 6 (6.6) 40 (8.3) 22 (20.0) 69 (5.8)
Abortion severity
Severe maternal outcome 16 (3.2) 1 (1.10) 4 (0.8) 4 (3.6) 25 (2.1)
Potentially life- threatening 
condition
61 (12.0) 9 (9.9) 23 (4.8) 18 (16.4) 111 (9.3)
Moderate 314 (61.9) 65 (71.4) 234 (48.6) 50 (45.5) 663 (55.7)
Mild 116 (22.9) 16 (17.6) 221 (45.9) 38 (34.6) 391 (32.9)
Facility level
Primary/secondary 232 (45.8) 50 (55.0) 425 (88.2) 11 (10.0) 718 (60.3)
Tertiary 275 (54.2) 41 (45.1) 57 (11.8) 99 (90.0) 472 (39.7)
(Continues)
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receive a contraceptive compared with women who did receive 
counselling (AOR 4.01; 95% CI, 2.88– 5.59).
The stratum- specific odds ratios (Table S2) show how the rela-
tionship between each independent risk factor and nonreceipt of 
a contraceptive varied by country, adjusting for confounders. We 
found some evidence that the association between contraceptive 
counselling and the odds of nonreceipt of contraception varies be-
tween the four countries (P = 0.04).
4  | DISCUSSION
In this study, we found that 33.9% of women seeking care in 
facilities for abortion- related complications in Kenya, Malawi, 
Mozambique, and Uganda left the facility without a contracep-
tive or prescription for a contraceptive. This varied between 
the different countries, from 18.7% in Mozambique to 54.6% in 
Uganda. This wide range of estimates is of a similar magnitude to 
earlier studies from Sub- Saharan Africa,6,8,9 indicating that levels 
of nonreceipt of contraception vary substantially across different 
settings. Similarly, we found some important between- country 
differences in women's preference for certain types of contracep-
tives. In Malawi, for example, over 80% of women expressed a 
preference for any LARC compared with just over 20% of women 
in Mozambique.
We found evidence that women who attended facilities in urban 
areas, those who had not had a previous pregnancy, and those 
who did not receive contraceptive counselling were more likely to 
leave the facility without a contraceptive. Women in urban areas 
had higher levels of nonreceipt of a contraceptive compared with 
women in nonurban areas; this is most likely explained by greater 
service availability in urban areas meaning women can choose to 
source contraceptives from other outlets. Drawing on data from 
the MCS- A, Qureshi et al.14 showed that single women were more 
likely to have severe postabortion complications than other women, 
suggesting this is a particularly vulnerable group. Previous studies in 
Eastern Africa have found that single women are more likely to have 
unmet need for contraception compared with married women.15 This 
is likely to be due, at least in part, to cultural perceptions of young 
women's sexuality and stigmatization against premarital sex, with 
service providers unlikely to offer contraceptives to young women 
and young women unlikely to demand them.16,17 We saw a trend 
toward higher levels of single women leaving the facility without a 
contraceptive compared with married women, but no statistical ev-
idence for an association between marital status and nonreceipt of 
contraception. Whilst we did find evidence that women who had not 
had a previous pregnancy were more likely to have nonreceipt of 
contraception, we found no evidence that women who previously 
had an abortion, potentially a particularly vulnerable group for hav-
ing a repeat abortion, had different levels of nonreceipt of contra-
ception compared with women who did not report having a previous 
abortion in this study.
Our findings generally support existing studies that have identi-
fied the important role of contraceptive counselling in a woman's de-
cision to adopt contraceptives in PAC,18,19 although this was not the 
case across all the countries in our study. In Mozambique, there was 
no evidence for a difference in uptake of contraceptives between 
women who received counselling and women who did not. In the 
other three countries, women who did not receive counselling had 
Kenya (n = 507) Mozambique (n = 91) Malawi (n = 482) Uganda (n = 110) Total (n = 1190)
Contraceptive counselling
No 150 (29.6) 27 (29.7) 64 (13.3) 47 (42.7) 288 (24.2)
Yes 357 (70.4) 64 (70.3) 418 (86.7) 63 (57.3) 902 (75.8)
Received contraceptive or prescription for contraceptive
Yes 340 (67.1) 74 (81.3) 323 (67.0) 50 (45.5) 787 (66.1)
No 167 (32.9) 17 (18.7) 159 (33.0) 60 (54.6) 403 (33.9)
TA B L E  1  (Continued)
F I G U R E  2  Percentage of all women who reported a preference 
for at least one contraceptive method (n = 740), that reported 
preference for each method. Note that women could report a 
preference for more than one type of contraceptive. Women who 
were sterilised were excluded from this analysis. *Patch and ring 
not asked in Mozambique (n = 691). LARC, long- acting reversible 
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TA B L E  2  Association between potential risk factors (sociodemographic, clinical, and health service) and nonreceipt of contraception 
among women with abortion- related complications
Nonreceipt of contraception N (%) Crude OR (95% CI)a  P value Adjusted OR (95% CI)b  P valueb 
Sociodemographic characteristics
Age group, years
<20 81 (34.3) 1 1
20– 29 210 (36.4) 0.93 (0.70– 1.22) 0.92 (0.70– 1.21)
30+ 109 (31.0) 0.74 (0.54– 1.02) 0.15 0.74 (0.54– 1.02) 0.15
Marital status
Married/cohabiting 266 (32.6) 1 1
Single 101 (35.6) 1.31 (1.02– 1.68) 1.31 (1.03– 1.66)
Separated/divorced/widowed 10 (43.5) 1.71 (0.67– 4.35) 1.69 (0.66– 4.36)
Unknown 26 (38.2) 0.95 (0.66– 1.36) 0.07 0.93 (0.63– 1.36) 0.14
Gainful occupation
No 200 (32.8) 1 1
Yes 144 (34.4) 0.98 (0.76– 1.26) 0.96 (0.75– 1.22)
Unknown 59 (36.7) 0.95 (0.59– 1.54) 0.87 0.95 (0.57– 1.57) 0.94
Education level
None/some primary 72 (24.2) 0.82 (0.60– 1.11) 0.85 (0.63– 1.14)
Completed primary 129 (34.1) 1 1
Completed secondary 124 (38.4) 1.14 (0.88– 1.49) 1.14 (0.88– 1.47)
Unknown 78 (40.8) 1.08 (0.78– 1.51) 0.12 1.09 (0.78– 1.52) 0.18
Socioeconomic status
Low 69 (30.9) 1 1
Middle 239 (33.9) 1.09 (0.84– 1.40) 1.07 (0.83– 1.38)
High 94 (37.0) 1.25 (0.81– 1.93) 0.59 1.22 (0.80– 1.88) 0.65
Location of facility
Urban 291 (36.3) 1 1
Nonurban 112 (28.9) 0.52 (0.30– 0.91) 0.02 0.52 (0.30– 0.91) 0.02
Clinical characteristics
Any previous pregnancy
Yes 238 (30.4) 1 1
No 144 (39.9) 1.60 (1.15– 2.22) 0.005 1.60 (1.14– 2.24) 0.007
Any previous abortion
Yes 70 (34.0) 1 1
No 302 (33.0) 1.08 (0.73– 1.60) 0.91 (0.64– 1.29)
Missing/unknown 31 (44.9) 1.16 (0.53– 2.52) 0.88 0.57 (0.29– 1.14) 0.25
Abortion severity
Severe maternal outcome 5 (20.0) 0.84 (0.33– 2.12) 0.85 (0.35– 2.08)
Potentially life- threatening condition 39 (35.1) 1.11 (0.77– 1.59) 1.15 (0.78– 1.69)
Moderate 194 (29.3) 1 1
Mild 165 (42.2) 1.25 (0.91– 1.71) 0.47 1.24 (0.88– 1.75) 0.48
Health service characteristics
Facility level
Primary/secondary 211 (29.4) 1 1
Tertiary 192 (40.7) 1.03 (0.58– 1.82) 0.92 0.85 (0.51– 1.44) 0.56
Contraceptive counselling
Yes 225 (24.9) 1 1
No 178 (61.8) 4.05 (2.90– 5.66) <0.001 4.01 (2.88– 5.59) <0.001
aCrude estimates adjusted for country.
bSociodemographic characteristics adjusted for country and location of facility where women accessed services; clinical characteristics adjusted 
for country, location of facility, and any previous pregnancy; health service characteristics adjusted for country, marital status, location, and 
contraceptive counselling.
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around four to five times the odds of not receiving a contraceptive. 
However, we do need to be cautious in our interpretation that con-
traceptive counselling led to uptake of contraceptives in the absence 
of information on whether women received counseling because they 
asked about family planning in the first place or whether the coun-
seling was provider initiated. While no data were collected to un-
derstand the quality of the contraceptive counselling in this study, 
we noted that the main reason that women reported not getting a 
contraceptive was fear of adverse effects, suggesting shortcomings 
in the provision of high- quality family planning counselling. Inherent 
in good- quality contraceptive information and services is informa-
tion delivery in a way that ensures fully informed decision- making, 
which respects the individual's autonomy, privacy, and confidential-
ity, and is sensitive to women's needs and perspectives.20 A recent 
systematic review on effective counselling strategies found that de-
tailed contraceptive counselling increased contraceptive uptake in 
women; however, there were no studies identified as part of the re-
view looking specifically at interventions to increase uptake among 
women with abortion- related complications in Sub- Saharan Africa, 
indicating an important area for future research.21
A key strength of this study was the comprehensiveness of the 
WHO MCS- A dataset, which used multistage sampling and had 
three data sources, allowing for exploration of numerous determi-
nants, from sociodemographic and clinical characteristics of women 
to facility- level information. However, there were also some limita-
tions. Firstly, as the data were not collected for the purposes of mea-
suring contraceptive preferences and determinants of postabortion 
contraceptive acceptance, there were some potentially important 
determinants of contraceptive uptake for which data were not col-
lected in this survey. Most notably is religion, which has been shown 
to be a determinant of contraceptive uptake in other studies.22 It 
would have also been helpful to have collected detailed information 
on women's fertility intentions, which would have enabled us to as-
sess whether women received a contraceptive method that corre-
sponds with that intention. Secondly, the inclusion of only women 
attending high- volume facilities with surgical capacity who were 
hospitalized for more than 24 h could limit the generalizability of 
these results and limit comparison with studies that include women 
attending for PAC at lower- level facilities or women with less severe 
complications. Thirdly, the sample includes both women who had 
complications following a spontaneous abortion as well as an in-
duced abortion, and it is not possible to know how many women fall 
into each of the groups in this study population. These two groups 
of women will have different needs in relation to counselling and 
contraception. Finally, these data were only cross- sectional, thus we 
do not know whether women initiated and continued using contra-
ceptives nor if they were satisfied with the method.
At the 1994 International Conference on Population and 
Development and the more recent 25th Anniversary of the confer-
ence, 179 country leaders agreed to ensure quality services for abor-
tion complications were available— irrespective of the legal status of 
abortion— and that this would include counselling and provision of 
contraceptives.23,24 As we have demonstrated in the present study, 
there remains a need to continue improving access to contraceptives 
for women who have had an abortion- related complication. Given 
the important relationship between counselling and contraceptive 
acceptance demonstrated in the study, all women should receive 
high- quality contraceptive information services and counselling, if 
desired, at the facility to increase contraceptive acceptance.
ACKNOWLEDGMENTS
The WHO Multi- Country Survey on Abortion (MCS- A) is a research 
project implemented by the WHO across a network of health facili-
ties in Africa. We sincerely thank the women who participated in this 
study. WHO is grateful to the extensive network of institutions and 
individuals who contributed to the project design and implementa-
tion, including researchers, study coordinators, data collectors, data 
clerks, and other partners including the staff from the Ministries 
of Health and WHO country offices. This research was funded by 
the UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme 
of Research, Development and Research Training in Human 
Reproduction (HRP), Department of Sexual and Reproductive Health 
and Research, World Health Organization, Geneva, Switzerland.
CONFLIC TS OF INTERE S T
Outside of the submitted work, CC reports consultancy fees to her 
institute received from WHO. Other authors have no conflicts of 
interest.
AUTHOR CONTRIBUTIONS
ZQ, AJ, VF, CC, HM, and OT conceptualized the study. AJ and CC 
conducted the analysis. ZQ and AJ wrote the first draft of the paper. 
VR, GG, AO, HM, AB, FAB, RC, LG, CRK, ATM, OT, and CC reviewed 
and provided critical input on the draft.
R E FE R E N C E S
 1. Bearak J, Popinchalk A, Ganatra B, et al. Unintended pregnancy 
and abortion by income, region, and the legal status of abortion: 
estimates from a comprehensive model for 1990– 2019. Lancet Glob 
Health. 2020;8:e1152- e1161.
 2. Ganatra B, Gerdts C, Rossier C, et al. Global, regional, and subre-
gional classification of abortions by safety, 2010– 14: estimates 
from a Bayesian hierarchical model. Lancet. 2017;390:2372- 2381.
 3. Royal College of Obstetricians Gynaecologists. Best Practice in 
Comprehensive Abortion Care. Best Practice Paper No. 2 June 2015. 
RCOG; 2015.
 4. World Health Organization. Health Worker Roles in Providing Safe 
Abortion Care and post Abortion Contraception. WHO; 2015.
 5. Shah IH, Santhya KG, Cleland J. Postpartum and post- abortion 
contraception: from research to programs. Stud Family Plann. 
2015;46:343- 353.
 6. Izugbara C, Wekesah FM, Sebany M, Echoka E, Amo- Adjei J, Muga 
W. Availability, accessibility and utilization of post- abortion care in 
Sub- Saharan Africa: a systematic review. Health Care Women Int. 
2020;41:732- 760.
 7. Rominski SD, Morhe ES, Lori J. Post- abortion contraception 
choices of women in Ghana: a one- year review. Glob Public Health. 
2015;10:345- 353.
 8. Asrat M, Bekele D, Rominski SD. Post- abortion contraceptive ac-
ceptance and choice among women receiving abortion care at Saint 
    | 9QURESHI Et al.
Paul's Hospital, Addis Ababa, Ethiopia: a cross- sectional study. 
Lancet Glob Health. 2018;6:S37.
 9. Rasch V, Massawe S, Yambesi F, Bergstrom S. Acceptance of con-
traceptives among women who had an unsafe abortion in Dar es 
Salaam. Trop Med Int Health. 2004;9:399- 405.
 10. Packer C, Pack AP, McCarraher DR. Voluntary contraceptive up-
take among postabortion care clients treated with Misoprostol in 
Rwanda. Glob Health: Sci Pract. 2019;7(suppl 2):S247- S257.
 11. Huber D, Curtis C, Irani L, Pappa S, Arrington L. Postabortion care: 
20 years of strong evidence on emergency treatment, family plan-
ning, and other programming components. Glob Health: Sci Pract. 
2016;4:481- 494.
 12. Tripney J, Bird K, Kwan I, Kavanagh J. The Impact of Post- Abortion 
Care Family Planning Counselling and Services in Low- Income 
Countries: A Systematic Review of the Evidence (Technical Report). 
EPPI- Centre, Social Science Research Unit, Institute of Education, 
University of London; 2011.
 13. Kim CR, Tunçalp Ö, Ganatra B, Gülmezoglu AM. WHO multi- country 
survey on abortion- related morbidity and mortality in health facili-
ties: study protocol. BMJ Global Health. 2016;1(3):e000113.
 14. Qureshi Z, Mehrtash H, Kouanda S, et al. Understanding abortion- 
related complications in health facilities: results from WHO multi-
country survey on abortion (MCS- A) across 11 sub- Saharan African 
countries. BMJ Global Health. 2021;6:e003702.
 15. Makenzius M, Faxelid E, Gemzell- Danielsson K, Odero TMA, 
Klingberg- Allvin M, Oguttu M. Contraceptive uptake in post abor-
tion care- secondary outcomes from a randomised controlled trial, 
Kisumu, Kenya. PLoS One. 2018;13:e0201214.
 16. Izugbara CO, Egesa C, Okelo R. ‘High profile health facilities can 
add to your trouble’: women, stigma and un/safe abortion in Kenya. 
Soc Sci Med. 2015;141:9- 18.
 17. Håkansson M, Oguttu M, Gemzell- Danielsson K, Makenzius M. 
Human rights versus societal norms: a mixed methods study among 
healthcare providers on social stigma related to adolescent abor-
tion and contraceptive use in Kisumu, Kenya. BMJ Glob Health. 
2018;3:e000608.
 18. Benson J, Andersen K, Healy J, Brahmi D. What factors contribute 
to postabortion contraceptive uptake by young women? A program 
evaluation in 10 countries in Asia and sub- Saharan Africa. Glob 
Health Sci Pract. 2017;5:644- 657.
 19. Kokeb L, Admassu E, Kassa H, Seyoum T. Utilization of post abor-
tion contraceptive and associated factors among women who came 
for abortion service: a hospital based cross sectional study. J Fam 
Med Dis Prev. 2015;1:10.23937/ 2469- 5793/1510022
 20. World Health Organization. Ensuring Human Rights in the 
Provision of Contraceptive Information and Services: Guidance and 
Recommendations. WHO; 2014.
 21. Cavallaro FL, Benova L, Owolabi OO, Ali M. A systematic review 
of the effectiveness of counselling strategies for modern contra-
ceptive methods: what works and what doesn’t? BMJ Sex Reprod 
Health. 2020;46:254- 269.
 22. Rasch V, Yambesi F, Kipingili R. Scaling up postabortion contracep-
tive service– results from a study conducted among women having 
unwanted pregnancies in urban and rural Tanzania. Contraception. 
2005;72:377- 382.
 23. United Nations Population Fund. Programme of Action. Adopted at 
the International Conference on Population and Development Cairo, 
5– 13 September 1994. New York: UNFPA; 2014.
 24. Nairobi Summit on ICPD25 commitments. Accessed February 17, 
2021. https://www.nairo bisum mitic pd.org/commi tments
SUPPORTING INFORMATION
Additional supporting information may be found online in the 
Supporting Information section.
How to cite this article: Qureshi Z, Jamner A, Filippi V, et al. 
Level and determinants of contraceptive uptake among 
women attending facilities with abortion- related 
complications in East and Southern Africa. Int J Gynecol 
Obstet. 2021;00:1– 9. https://doi.org/10.1002/ijgo.13898
